An overview of gene-epigenetic-environmental contributions to MS causation

Journal of the Neurological Sciences

Volumn 286, Issue 1-2, 2009, Pages 54-57

  Lincoln, John A ^a   Cook, Stuart D ^a  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

EBV infection; Environmental factors; Gangliosides; Multiple sclerosis; Smoking; Vitamin D

Indexed keywords

DNA; GANGLIOSIDE; VITAMIN D; VITAMIN D RECEPTOR;

ARTICLE; AUTOIMMUNE DISEASE; CIGARETTE SMOKING; DIETARY INTAKE; DISEASE PREDISPOSITION; DNA SEQUENCE; ENVIRONMENTAL FACTOR; EPIGENETICS; EPSTEIN BARR VIRUS; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HELMINTHIASIS; HUMAN; INCIDENCE; MULTIPLE SCLEROSIS; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS INFECTION; VITAMIN D DEFICIENCY;

ANIMALS; ENVIRONMENT; EPISTASIS, GENETIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MULTIPLE SCLEROSIS;

EID: 70349769201     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2009.06.037     Document Type: Article

References (62)

1. Casaccia-Bonnefil P., Pandozy G., and Mastronardi F. Evaluating epigenetic landmarks in the brain of multiple sclerosis patients: a contribution to the current debate on disease pathogenesis. Prog Neurobiol 86 (2008) 368-378
2. Sadovnick A.D., Duquette P., Herrera B., Yee I.M., and Ebers G.C. A timing-of-birth effect on multiple sclerosis clinical phenotype. Neurology 69 (2007) 60-62
3. Ebers G.C., and Dyment D.A. Genetics of multiple sclerosis. Semin Neurol 18 (1998) 295-299
4. Sadovnick A.D., Ebers G.C., Dyment D.A., and Risch N.J. Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group. Lancet 347 (1996) 1728-1730
5. Ebers G.C., Sadovnick A.D., and Risch N.J. A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group. Nature 377 (1995) 150-151
6. Ebers G.C., Bulman D.E., Sadovnick A.D., Paty D.W., Warren S., Harder W., et al. A population-based study of multiple sclerosis in twins. New Engl J Med 315 (1986) 1638-1642
7. Weinshenker B.G., Santrach P., Bissonet A.S., McDonnel S.K., Schaid D., Moore S.B., et al. Major histocompatibility complex class II alleles and the course and outcome of MS: a population-based study. Neurology 51 (1998) 742-747
8. Hillert J., and Olerup O. Multiple sclerosis is associated with genes within or close to the HLA-DR-DQ subregion on a normal DR15, DQ6, Dw2 haplotype. Neurology 43 (1993) 163-168
9. International Multiple Sclerosis Genetics Consortium, Hafler D.A., Compston A., Sawcer S., Lander E.S., Daly M.J., et al. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 315 (2007) 1638-1642
10. Lundmark F., Duvefelt K., and Hillert J. Genetic association analysis of the interleukin 7 gene (IL7) in multiple sclerosis. Neuroimmunology 192 (2007) 171-173
11. Lundmark F., Duvefelt K., Iacobaeus E., Kockum I., Wallström E., Khademi M., et al. Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nat Genet 39 (2007) 1108-1113
12. Husain S., Yildirim-Toruner C., Rubio J.P., Field J., Southern MS Genetics Consortium, Schwalb M., et al. Variants of ST8SIA1 are associated with risk of developing multiple sclerosis. PLoS ONE 3 (2008) e2653
13. Simon B.M., Malisan F., Testi R., Nicotera P., and Leist M. Disialoganglioside GD3 is released by microglia and induces oligodendrocyte apoptosis. Cell Death Differ 9 (2002) 758-767
14. Andersson L.M., Fredman P., Lekman A., Rosengren L., and Gisslén M. Increased cerebrospinal fluid ganglioside GD3 concentrations as a marker of microglial activation in HIV type 1 infection. Aids Res Hum Retrovir 14 (1998) 1065-1069
15. Dowling P., Husar W., Menonna J., Donnenfeld H., Cook S., and Sidhu M. Cell death and birth in multiple sclerosis brain. J Neurol Sci 149 (1997) 1-11
16. Barnett M.H., and Prineas J.W. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 55 (2004) 458-468
17. Claus C., Schlaak J., Dittmayer M., Meyer zum Büschenfelde K., and Dippold W. Inhibition of anti-GD3-ganglioside antibody-induced proliferation of human CD8+ T cells by CD16+ natural killer cells. Eur J Immunol 24 (1994) 1208-1212
18. Homma T., Hosono O., Iwata S., Ando S., Sasaki K., Nishi T., et al. Recognition of cell surface GD3 by monoclonal antibody anti-6C2 in rheumatoid arthritis synovial fluid: expression on human T cells with transendothelial migratory activity. Arthritis Rheum 44 (2001) 296-306
19. Okada M., Itoh M.M., Haraguchi M., Okajima T., Inoue M., Oishi H., et al. b-series Ganglioside deficiency exhibits no definite changes in the neurogenesis and the sensitivity to Fas-mediated apoptosis but impairs regeneration of the lesioned hypoglossal nerve. J Biol Chem 277 (2002) 1633-1636
20. Ascherio A., and Munger K.L. Environmental risk factors for multiple sclerosis. Part II: noninfectious factors. Ann Neurol 61 (2007) 504-513
21. Kurtzke J.F., Beebe G.W., and Norman J.E. Epidemiology of multiple sclerosis in US veterans: III. Migration and the risk of MS. Neurology 35 (1985) 672-678
22. Orton S.M., Herrera B.M., Yee I.M., Valdar W., Ramagopalan S.V., Sadovnick A.D., et al. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol 5 (2006) 932-936
23. Grimaldi L.M., Palmeri B., Salemi G., Giglia G., D'Amelio M., Grimaldi R., et al. High prevalence and fast rising incidence of multiple sclerosis in Caltanissetta, Sicily, southern Italy. Neuroepioemiology 28 (2007) 28-32
24. Alonso A., and Hernán M.A. Temporal trends in the incidence of multiple sclerosis: a systematic review. Neurology 70 Suppl 1 (2008) A333
25. Wallin M.T., Page W.F., and Kurtzke J.F. Multiple sclerosis in US veterans of the Vietnam era and later military service: race, sex, and geography. Ann Neurol 55 (2004) 65-71
26. Giovannonia G., and Ebers G. Multiple sclerosis: the environment and causation. Curr Opin Neurol 20 (2007) 261-268
27. Poskanzer D.C., Walker A.M., Yonkondy J., and Sheridan J.L. Studies in the epidemiology of multiple sclerosis in the Orkney and Shetland Islands. Neurology 26 (1976) 14-17
28. Cohen J.I. Epstein-Barr virus infection. N Engl J Med 343 (2000) 481-492
29. Wolfson C. Multiple sclerosis and antecedent infections. Epidemiology 12 (2001) 298-299
30. Marrie R.A., Wolfson C., Stukenboom M.C., Gout O., Heinzlef O., Roullet E., et al. Multiple sclerosis and antecedent infections; a case-control study. Neurology 54 (2000) 2307-2310
31. Lindberg C., Andersen O., Vahlne A., Dalton M., and Runmarker B. Epidemiological investigation of the association between infectious mononucleosis and multiple sclerosis. Neuroepidem 10 (1991) 62-65
32. Haahr S., Koch-Henriksen N., Moller-Larsen A., Eriksen L.S., and Andersen H.M. Increased risk of multiple sclerosis after late Epstein Barr virus infection. Mult Scler 1 (1995) 73-77
33. Alotaibi S., Kennedy J., Tellier R., Stephens D., and Banwell B. Epstein-Barr virus in pediatric multiple sclerosis. J Am Med Assoc 291 (2004) 1875-1879
34. Lünemann J.D., and Münz C. Epstein-Barr virus and multiple sclerosis. Curr Neurol Neurosci Rep 7 (2007) 253-258
35. Pohl D., Krone B., Rostasy K., Kahler E., Brunner E., Lehnert M., et al. High seroprevalence of Epstein-Barr virus in children with multiple sclerosis. Neurology 67 (2006) 2063-2065
36. Banwell B., Krupp L., Kennedy J., Tellier R., Tenembaum S., Ness J., et al. Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study. Lancet Neurol 6 (2007) 773-781
37. Rand K.H., Houck H., Denslow N.D., and Heilman K.M. Epstein-Barr virus nuclear antigen-1 (EBNA-1) associated oligoclonal bands in patients with multiple sclerosis. J Neurol Sci 173 (2000) 32-39
38. Cepok S., Zhou D., Srivastava R., Nessler S., Stei S., Büssow K., et al. Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis. J Clin Invest 115 (2005) 1352-1360
39. Serafini B., Rosicarelli B., Franciotta D., Magliozzi R., Reynolds R., Cinque P., et al. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med 204 (2007) 2899-2912
40. Cook S.D. Does epstein-barr virus cause multiple sclerosis?. Rev Neurol Dis 1 (2004) 115-123
41. Lincoln J.A., Hankiewicz K., and Cook S.D. Could Epstein-Barr virus or canine distemper virus cause multiple sclerosis?. Neurol Clin 26 (2008) 699-715
42. Hernán M.A., Jick S.S., Logroscino G., Olek M.J., Ascherio A., and Jick H. Cigarette smoking and the progression of multiple sclerosis. Brain 128 (2005) 1461-1465
43. Pekmezovic T., Drulovic J., Milenkovic M., Jarebinski M., Stojsavljevic N., Mesaros S., et al. Lifestyle factors and multiple sclerosis: a case-control study in Belgrade. Neuroepidemiology 27 (2006) 212-216
44. Hernán M.A., Olek M.J., and Ascherio A. Cigarette smoking and incidence of multiple sclerosis. Am J Epidemiol 154 (2001) 69-74
45. Mikaeloff Y., Caridade G., Tardieu M., Suissa S., and KIDSEP study group. Parental smoking at home and the risk of childhood-onset multiple sclerosis in children. Brain 130 (2007) 2589-2595
46. Costenbader K.H., and Karlson E.W. Cigarette smoking and autoimmune disease: what can we learn from epidemiology?. Lupus 15 (2006) 737-745
47. Klareskog L., Stolt P., Lundberg K., Källberg H., Bengtsson C., Grunewald J., et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 54 (2006) 38-46
48. Sundström P., Nyström L., and Hallmans G. Smoke exposure increases the risk for multiple sclerosis. Eur J Neurol 15 (2008) 579-583
49. Holick M.F. Vitamin D deficiency. N Engl J Med 357 (2007) 266-281
50. Goldberg P. Multiple sclerosis: vitamin D and calcium as environmental determinants of prevalence (a viewpoint). Part 1: sunlight, dietary factors and epidemiology. Int J Environ Stud 6 (1974) 19-27
51. Swank R.L., Lerstad O., Strøm A., and Backer J. Multiple sclerosis in rural Norway its geographic and occupational incidence in relation to nutrition. N Engl J Med 246 (1952) 721-728
52. Kurtzke J.F. On the fine structure of the distribution of multiple sclerosis. Acta Neurol Scand 43 (1967) 257-282
53. Freedman D.M., Dosemeci M., and Alavanja M.C. Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: a case-control study based on death certificates. Occup Environ Med 57 (2000) 418-421
54. Leibowitz U., Sharon D., and Alter M. Geographical considerations in multiple sclerosis. Brain 90 (1967) 871-886
55. van der Mei I.A.F., Ponsonby A.L., Dwyer T., Blizzard L., Simmons R., Taylor B.V., et al. Past exposure to sun, skin phenotype and risk of multiple sclerosis: a casecontrol study. BMJ 327 (2003) 316-321
56. Munger K.L., Zhang S.M., O'Reilly E., Hernán M.A., Olek M.J., Willett W.C., et al. Vitamin D intake and incidence of multiple sclerosis. Neurology 62 (2004) 60-65
57. Munger K.L., Levin L.I., Hollis B.W., Howard N.S., and Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. J Am Med Assoc 296 (2006) 2832-2838
58. Elliott D.E., Summers R.W., and Weinstock J.V. Helminths as governors of immune-mediated inflammation. Int J Parasitol 37 (2007) 457-464
59. Correale J., Farez M., and Razzitte G. Helminth infections associated with multiple sclerosis induce regulatory B cells. Ann Neurol 64 (2008) 187-199
60. Sadovnick A.D., Duquette P., Herrera B., Yee I.M., and Ebers G.C. A timing-of-birth effect on multiple sclerosis clinical phenotype. Neurology 69 (2007) 60-62
61. Lang H.L., Jacobsen H., Ikemizu S., Andersson C., Harlos K., Madsen L., et al. A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat Immunol 3 (2002) 940-943
62. Pender M.P. Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases. Trends Immunol 24 (2003) 584-588